Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Pharmaceuticals & Biotech

Discovery & Preclinical Targets, assays, animal models, and early safety/tox studies before human trials. Clinical Trials (Phases I–IV) Design, endpoints, enrollment, interim reads, and post‑market surveillance. Approvals, Safety & REMS FDA/EMA decisions, boxed warnings, pharmacovigilance, and label changes. Generics & Biosimilars Access, interchangeability, litigation, and pricing dynamics for follow‑ons. Vaccines & Immunization Platforms (mRNA, viral vector), boosters, schedules, and cold‑chain supply. Cell & Gene Therapies CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up. Manufacturing & Supply APIs, sterile fill‑finish, shortages, and quality systems across the supply chain.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech


allsci.com > news > clinical-trials > sab01-clinical-trial-santa-ana-bio-advances

Santa Ana Bio takes KIT/Siglec-6 bispecific SAB01 into first-in-human testing

7+ hour, 45+ min ago   (376+ words) AllSci California-based Santa Ana Bio has dosed the first cohort in a first-in-human trial of SAB01, a bispecific antibody designed to deplete mast cells selectively by co-engaging KIT and Siglec-6. The molecule's design addresses the following: existing KIT-targeted antibodies produce rapid…...


medicaldaily.com > giggle-incontinence-atomoxetine-case-report-478600

Laughter Emptied This Child's Bladder for Years Until a Nonstimulant ADHD Drug Put It into Remission

10+ hour, 32+ min ago   (645+ words) Laughter is the entire trigger. Not coughing, not sneezing, not jumping. A joke lands, the bladder empties, and the child cannot stop it once it starts. Giggle incontinence, also called enuresis risoria, is a bladder storage disorder in which laughter…...


brusselstimes.com > eu-affairs > 2317358 > eu-backed-investment-fuels-nasal-spray-trials-for-viral-lung-treatments

EU-backed investment fuels nasal spray trials for viral lung treatments

4+ hour, 57+ min ago   (13+ words) The Brussels Times...


sdvoice.info > on-your-november-ballot-prop-38

On Your November Ballot: Prop 38 Would Allocate $8.4 Billion to Immunology and Immunotherapy Funding

1+ hour, 52+ min ago   (317+ words) California voters will decide in November whether Proposition (Prop) 38 should authorize substantial state funding for immunology and immunotherapy research. The initiative would fund immunology and immunotherapy research aimed at harnessing the body’s immune system to develop new treatments, medical procedures…...


biospace.com > drug-delivery > aam-sounds-alarm-on-unsustainable-race-to-the-bottom-for-generics-and-biosimilars

AAM sounds alarm on ‘unsustainable, race to the bottom’ for generics and biosimilars

1+ hour, 5+ min ago   (373+ words) The Association for Accessible Medicines (AAM) has reiterated its concerns about the sustainability of prices for off-patent drugs, warning that a “race to the bottom” may force companies to exit the market. America could lose “the backbone of affordable healthcare…...


quiverquant.com > news > Ascendis+Pharma+Regains+Rights+to+TransCon+Metabolic+and+Cardiovascular+Programs%2C+Including+Once-Monthly+TransCon+Semaglutide

Ascendis Pharma Regains Rights to TransCon Metabolic and Cardiovascular Programs, Including Once-Monthly TransCon Semaglutide | ASND Stock News

53+ min ago   (210+ words) TransCon Semaglutide is an investigational long-acting prodrug of the GLP-1 receptor agonist semaglutide, aimed at treating obesity and type 2 diabetes. Ascendis plans to initiate multiple programs targeting various metabolic and cardiovascular diseases, focusing on areas with significant unmet medical needs....


urotoday.com > video-lectures > mcrpc-treatment > video > 5873-sequencing-radium-223-and-lutetium-177-psma-in-metastatic-castration-resistant-prostate-cancer-dana-rathkopf-irbaz-bin-riaz.html

Sequencing Radium-223 and Lutetium-177 PSMA in Metastatic Castration-Resistant Prostate Cancer - Dana Rathkopf & Irbaz Bin Riaz

4+ hour, 46+ min ago   (568+ words) UroToday...


fredhutch.org > en > news > center-news > 2026 > 09 > reiner-sickle-cell-trait.html

Exploring the health impacts of sickle cell trait

2+ hour, 8+ min ago   (1390+ words) An exploration of large patient biobanks linked to clinical information has revealed new health conditions associated with sickle cell trait, the status of carrying just one beta globin gene with the sickle cell mutation. (People with two mutated copies get…...


kpcw.org > show > local-news-hour > 2026-09-14 > summit-county-health-vaccine-clinics-set-for-early-october

Summit County health vaccine clinics set for early October

4+ hour, 55+ min ago   (87+ words) KPCW Summit County health vaccine clinics set for early October Summit County Health Department Deputy Director Kendra Babitz discusses the department's seasonal vaccine clinics, vaccine options, and measles immunization outreach. She says the annual drive-though and walk-up clinics will have…...


statnews.com > 09/14/2026 > rfk-speech-childrens-health-defense-conference-washington

Kennedy to deliver keynote for anti-vaccine group he once led

1+ hour, 12+ min ago   (303+ words) WASHINGTON — Health Secretary Robert F. Kennedy Jr. will give a keynote address at a Children’s Health Defense conference in the nation’s capital this week, embracing the anti-vaccine organization he once led. “We couldn’t be more excited to welcome our founder…...